-1::1
Simple Hit Counter
Skip to content

Products

Solutions

×
×
Sign In

EN

EN - EnglishCN - 简体中文DE - DeutschES - EspañolKR - 한국어IT - ItalianoFR - FrançaisPT - Português do BrasilPL - PolskiHE - עִבְרִיתRU - РусскийJA - 日本語TR - TürkçeAR - العربية
Sign In Start Free Trial

RESEARCH

JoVE Journal

Peer reviewed scientific video journal

Behavior
Biochemistry
Bioengineering
Biology
Cancer Research
Chemistry
Developmental Biology
View All
JoVE Encyclopedia of Experiments

Video encyclopedia of advanced research methods

Biological Techniques
Biology
Cancer Research
Immunology
Neuroscience
Microbiology
JoVE Visualize

Visualizing science through experiment videos

EDUCATION

JoVE Core

Video textbooks for undergraduate courses

Analytical Chemistry
Anatomy and Physiology
Biology
Calculus
Cell Biology
Chemistry
Civil Engineering
Electrical Engineering
View All
JoVE Science Education

Visual demonstrations of key scientific experiments

Advanced Biology
Basic Biology
Chemistry
View All
JoVE Lab Manual

Videos of experiments for undergraduate lab courses

Biology
Chemistry

BUSINESS

JoVE Business

Video textbooks for business education

Accounting
Finance
Macroeconomics
Marketing
Microeconomics

OTHERS

JoVE Quiz

Interactive video based quizzes for formative assessments

Authors

Teaching Faculty

Librarians

K12 Schools

Biopharma

Products

RESEARCH

JoVE Journal

Peer reviewed scientific video journal

JoVE Encyclopedia of Experiments

Video encyclopedia of advanced research methods

JoVE Visualize

Visualizing science through experiment videos

EDUCATION

JoVE Core

Video textbooks for undergraduates

JoVE Science Education

Visual demonstrations of key scientific experiments

JoVE Lab Manual

Videos of experiments for undergraduate lab courses

BUSINESS

JoVE Business

Video textbooks for business education

OTHERS

JoVE Quiz

Interactive video based quizzes for formative assessments

Solutions

Authors
Teaching Faculty
Librarians
K12 Schools
Biopharma

Language

English

EN

English

CN

简体中文

DE

Deutsch

ES

Español

KR

한국어

IT

Italiano

FR

Français

PT

Português do Brasil

PL

Polski

HE

עִבְרִית

RU

Русский

JA

日本語

TR

Türkçe

AR

العربية

    Menu

    JoVE Journal

    Behavior

    Biochemistry

    Bioengineering

    Biology

    Cancer Research

    Chemistry

    Developmental Biology

    Engineering

    Environment

    Genetics

    Immunology and Infection

    Medicine

    Neuroscience

    Menu

    JoVE Encyclopedia of Experiments

    Biological Techniques

    Biology

    Cancer Research

    Immunology

    Neuroscience

    Microbiology

    Menu

    JoVE Core

    Analytical Chemistry

    Anatomy and Physiology

    Biology

    Calculus

    Cell Biology

    Chemistry

    Civil Engineering

    Electrical Engineering

    Introduction to Psychology

    Mechanical Engineering

    Medical-Surgical Nursing

    View All

    Menu

    JoVE Science Education

    Advanced Biology

    Basic Biology

    Chemistry

    Clinical Skills

    Engineering

    Environmental Sciences

    Physics

    Psychology

    View All

    Menu

    JoVE Lab Manual

    Biology

    Chemistry

    Menu

    JoVE Business

    Accounting

    Finance

    Macroeconomics

    Marketing

    Microeconomics

Start Free Trial
Loading...
Home
JoVE Journal
Genetics
Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants ...
Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants ...
JoVE Journal
Genetics
This content is Free Access.
JoVE Journal Genetics
Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease

Full Text
34,951 Views
09:34 min
April 4, 2018

DOI: 10.3791/57266-v

Allison A. Dilliott1,2, Sali M.K. Farhan3, Mahdi Ghani4, Christine Sato4, Eric Liang5, Ming Zhang4, Adam D. McIntyre1, Henian Cao1, Lemuel Racacho6,7, John F. Robinson1, Michael J. Strong1,8, Mario Masellis9,10, Dennis E. Bulman6,7, Ekaterina Rogaeva4, Anthony Lang10,11, Carmela Tartaglia4,10, Elizabeth Finger12,13, Lorne Zinman9, John Turnbull14, Morris Freedman10,15, Rick Swartz9, Sandra E. Black9,16, Robert A. Hegele1,2

1Robarts Research Institute, Schulich School of Medicine and Dentistry,Western University, 2Department of Biochemistry, Schulich School of Medicine and Dentistry,Western University, 3Analytic and Translational Genetics Unit, Center for Genomic Medicine,Harvard Medical School, Massachusetts General Hospital, Stanley Centre for Psychiatric Research, Broad Institute of MIT and Harvard, 4Tanz Centre for Research in Neurodegenerative Diseases,University of Toronto, 5School of Medicine, Faculty of Health Sciences,Queen's University, 6Faculty of Medicine, Department of Biochemistry, Microbiology and Immunology,University of Ottawa, 7CHEO Research Institute, Faculty of Medicine,University of Ottawa, 8Department of Clinical Neurological Sciences,Western University, 9Division of Neurology, Department of Medicine, Sunnybrook Health Sciences Centre,University of Toronto, 10Division of Neurology, Department of Medicine,University of Toronto, 11Morton and Gloria Shulman Movement Disorders Centre,Toronto Western Hospital, 12Department of Clinical Neurological Sciences, Schulich School of Medicine and Dentistry,Western University, 13Parkwood Institute,St. Joseph's Health Care, 14Department of Medicine, Division of Neurology,McMaster University, 15Division of Neurology, Department of Medicine,Baycrest Health Sciences, 16Canadian Partnership for Stroke Recovery Sunnybrook Site, Sunnybrook Health Science Centre,University of Toronto

Overview

Targeted next-generation sequencing is a cost-effective method for identifying genetic variants associated with diseases, particularly neurodegenerative disorders. This protocol outlines the workflow for sequencing and the bioinformatics processes involved.

Key Study Components

Area of Science

  • Genetics
  • Bioinformatics
  • Neuroscience

Background

  • Targeted sequencing focuses on specific genomic regions of interest.
  • This method is efficient and cost-effective compared to other sequencing approaches.
  • It is particularly useful for studying genetically heterogeneous neurodegenerative diseases.
  • Bioinformatics processing can be complex and error-prone for newcomers.

Purpose of Study

  • To elucidate genetic determinants of constitutional diseases.
  • To improve diagnostic capabilities for neurodegenerative diseases.
  • To streamline the bioinformatics workflow for variant analysis.

Methods Used

  • Collection and processing of human blood samples.
  • DNA extraction and library preparation for sequencing.
  • Utilization of cloud-based computing for data management.
  • Designing a bioinformatics workflow for resequencing and variant calling.

Main Results

  • Successful identification of genetic variants linked to diseases.
  • Demonstrated efficiency in sequencing and data processing.
  • Established quality control metrics for sequencing runs.
  • Developed a robust bioinformatics workflow for analysis.

Conclusions

  • Targeted next-generation sequencing is a valuable tool for disease research.
  • Bioinformatics challenges can be addressed with proper workflow design.
  • This method has broad applications beyond neurodegenerative diseases.

Frequently Asked Questions

What is targeted next-generation sequencing?
It is a method that focuses on specific genomic regions to identify genetic variants associated with diseases.
How does this method benefit neurodegenerative disease research?
It allows for efficient analysis of known genetic loci associated with these diseases.
What are the main challenges in using this technique?
The bioinformatics processing can be complex and may introduce errors if not handled properly.
What type of samples are used for this sequencing?
Human blood samples are typically collected for DNA extraction.
How is data quality assessed in sequencing runs?
Quality metrics such as cluster density and alignment percentages are used to evaluate sequencing quality.
Can this method be applied to other diseases?
Yes, it can be used for various constitutional diseases with known genomic regions of interest.

Targeted next-generation sequencing is a time- and cost-efficient approach that is becoming increasingly popular in both disease research and clinical diagnostics. The protocol described here presents the complex workflow required for sequencing and the bioinformatics process used to identify genetic variants that contribute to disease.

The overall goal of targeted next-generation sequencing is to elucidate the genetic determinants of various constitutional diseases by focusing on genomic regions of particular interest. This method can help us answer key questions regarding a disease's genetic ideology, particularly when there are previously known genetic associations. This technique is highly efficient.

It produces millions of reads in a short period of time, we get them at a relatively low cost, there is relatively low computational burden, especially when we compare it with other next-generation sequencing approaches. The implications of the technique extend toward the diagnosis of neurodegenerative diseases, which are phenotypically and genetically heterogenous, but have many known associated genetic loci. Though this method is particularly directed towards neurodegenerative diseases, it could also be applied to various other constitutional diseases with previously identified genomic regions of interest.

Generally, individuals new to this method will struggle because the bioinformatic processing required for final rare-variant analysis can be computationally intensive and create many sources of error. In this procedure, human blood samples are collected in three, four milliliter EDTA K2 tubes to provide a total volume of about 12 milliliters. Centrifuge the blood samples at 750 times gravity for 20 minutes.

This will fraction each sample into an upper phase of plasma, a thin middle phase of leukocytes, and a bottom phase of erythrocytes. Pipette the plasma off of the top of the blood sample using a disposable transfer pipette. Dispense into multiple 500 microliter aliquots and store at negative 80 degrees Celsius for future biochemical analysis.

Extract DNA from the blood sample with a blood extraction kit according to the manufacturer's instructions. The extracted DNA is then used to prepare a sequencing library for next-generation sequencing. Once the sequencing run is complete, on a computer, find the files within the cloud-based computing environment by selecting Runs on the navigation panel.

Select the appropriate sequencing run to navigate to the run summary page. Select Download to obtain data from the cloud. From the dialog box that appears, select the FASTQ files as the file type to download and click Download.

From the Run Summary page of the cloud-based computing environment, navigate to Charts to analyze the quality of the sequencing run with the various figures produced by the computing environment. From the Run Charts page, find the figure labeled Data By Cycle, under Chart select Intensity, and under Channel select All Channels to produce the signal intensity plot. Within the Run Navigation panel, select the Indexing QC tab to find the Indexing Quality Control histogram, which is on the right-hand side of the page.

From the Run Summary page of the cloud-based computing environment, click Metrics within the Run navigation panel to navigate to the quality metrics. Under Density kelvin per millimeter squared, ensure the cluster density of the sequencing run is within the range recommended by the enrichment kit being used. In this case, 1, 200 to 1, 400 kelvin per millimeter squared.

Under the Total Percent greater than or equal to Q30, ensure that the value is greater than or equal to 85%reflecting the quality of the sequencing reads. Under Aligned ensure that the value is similar to the percentage of positive control that was included in the sequencing run. For example, if 1%positive control was used, the expected aligned percent would be approximately 1 to 5%and variations within a few decimal points are acceptable.

Begin this process by importing FASTQ sequencing reads into the data processing software. Within the navigation area, right click and select New Folder. Name the folder such that there is clarity as to the sequencing run that was performed.

From the toolbar at the top, select Import and from the dropdown list, choose the platform with which the sequencing was performed. For the purposes of ONDRISeq, Ilumina is chosen. In the dialog box, navigate to and select the FASTQ files from the sequencing run that is being processed.

From the General options of the dialog box, click the box beside Paired reads if sequencing used paired end chemistries. From the Paired read information of the dialog box, select Paired-end if the forward read FASTQ file appears before the reverse read in the file list. Set the Paired read minimum distance to one and maximum distance to 1000.

From the Ilumina options of the dialog box, select Remove failed reads. From the Quality score drop down list, select the NGS pipeline that was utilized for sequencing. Select Next at the bottom of the dialog box.

Select Save and Create subfolders per batch unit. Select Next at the bottom of the dialog box. Choose the folder that was created earlier.

This is where the FASTQ files will be imported. Select Finish at the bottom of the dialog box and wait until the FASTQ files are imported. Click the Processes tab to see the status of the file import.

Next, design a workflow within the software to perform resequencing and variant calling according to the manufacturer's instructions. Designing the resequencing and variant calling workflow is the most difficult aspect of this procedure. Our team researched best practices and used trial and error to come up with the most robust workflow to fit our needs.

To run the imported FASTQ sequencing read files through the customized bioinformatics workflow, start by identifying the workflow in the software's toolbox and double-clicking it. Within the dialog box that appears, locate the folders of FASTQ files that were imported within the navigation area. Highlight all folders by selecting them within the navigation area and then click the box beside Batch.

Use the right-facing arrow to move the files to selected elements. Click Next at the bottom of the dialog box. Within the dialog box, review the batch overview to ensure the correct FASTQ files were selected and then click Next.

Review the steps of the workflow within the dialog box to ensure the correct files and export locations were selected when designing the workflow. These steps include mapping reads to the reference sequence, removing duplicate mapped reads, creating statistics for target regions, exporting BAM files, exporting Tab delimited text, filter based on overlap, and exporting VCF files. Within the final step in the dialog box, Result handling, select the option Save in input folder.

Click Finish at the bottom of the dialog box. The final step is to perform variant annotation upon the VCF file of each sample as described in the text protocol. The methodologies demonstrated in this video were applied to 528 participant DNA samples from individuals that have been enrolled in ONDRI.

Samples were run on the ONDRISeq panel in 22 runs of 24 samples per run. Overall, sequencing data were determined to be of high quality with a mean sample coverage of 78 times. A mean 95.6%of reads were matched to the reference sequence, and all ONDRISeq runs had greater than 90%of reads mapped.

Of the mapped reads, 92.0%and a Phred Score greater than or equal to Q30. To demonstrate the utility of this targeted NGS workflow, the example of a 68-year old male, Parkinson's disease patient is presented, showing a reduced N over output. Annotated variance are curated to identify those that are most likely to be of clinical significance, as denoted by the red boxes.

When performing this procedure, it is important to remember to appropriately cater the steps to the sequencing platform, the enrichment kit that was used and to the needs of the research. After its development, this technique paved the way for researchers in the field of genetics to obtain high quality, region specific data while remaining less expensive than its whole exome and whole genome counterparts.

Explore More Videos

Targeted Next-generation SequencingBioinformatics PipelineGenetic DeterminantsConstitutional DiseaseNeurodegenerative DiseasesBlood Sample ProcessingDNA ExtractionSequencing Library PreparationFASTQ File Download

Related Videos

A Strategy to Identify de Novo Mutations in Common Disorders such as Autism and Schizophrenia

05:51

A Strategy to Identify de Novo Mutations in Common Disorders such as Autism and Schizophrenia

Related Videos

26.5K Views

Detection of Rare Genomic Variants from Pooled Sequencing Using SPLINTER

14:06

Detection of Rare Genomic Variants from Pooled Sequencing Using SPLINTER

Related Videos

15.8K Views

Infinium Assay for Large-scale SNP Genotyping Applications

13:33

Infinium Assay for Large-scale SNP Genotyping Applications

Related Videos

40K Views

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors

11:15

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors

Related Videos

25.2K Views

Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies

13:24

Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies

Related Videos

12.3K Views

Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay (EMSA) and DNA-affinity Precipitation Assay (DAPA)

11:35

Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay (EMSA) and DNA-affinity Precipitation Assay (DAPA)

Related Videos

13.6K Views

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry

05:53

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry

Related Videos

10.8K Views

Pre-Implantation Genetic Testing for Aneuploidy on a Semiconductor Based Next-Generation Sequencing Platform

09:30

Pre-Implantation Genetic Testing for Aneuploidy on a Semiconductor Based Next-Generation Sequencing Platform

Related Videos

3.6K Views

Genetic Profiling and Genome-Scale Dropout Screening to Identify Therapeutic Targets in Mouse Models of Malignant Peripheral Nerve Sheath Tumor

09:33

Genetic Profiling and Genome-Scale Dropout Screening to Identify Therapeutic Targets in Mouse Models of Malignant Peripheral Nerve Sheath Tumor

Related Videos

1.8K Views

Detection of Copy Number Alterations Using Single Cell Sequencing

09:45

Detection of Copy Number Alterations Using Single Cell Sequencing

Related Videos

12.2K Views

JoVE logo
Contact Us Recommend to Library
Research
  • JoVE Journal
  • JoVE Encyclopedia of Experiments
  • JoVE Visualize
Business
  • JoVE Business
Education
  • JoVE Core
  • JoVE Science Education
  • JoVE Lab Manual
  • JoVE Quizzes
Solutions
  • Authors
  • Teaching Faculty
  • Librarians
  • K12 Schools
  • Biopharma
About JoVE
  • Overview
  • Leadership
Others
  • JoVE Newsletters
  • JoVE Help Center
  • Blogs
  • JoVE Newsroom
  • Site Maps
Contact Us Recommend to Library
JoVE logo

Copyright © 2026 MyJoVE Corporation. All rights reserved

Privacy Terms of Use Policies
WeChat QR code